Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Blue Sky Uranium Expands Drill Plan to Advance the Ivana Uranium-Vanadium Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Upstream Bio Inc UPB

Healthcare Biotechnology
Upstream Bio, Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist in clinical development, that targets the receptor for thymic stromal lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:UPB)

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

GlobeNewswire 8 days ago

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

GlobeNewswire March 12, 2025

Upstream Bio to Present at Upcoming March Investor Conferences

GlobeNewswire February 25, 2025

Automotive Security Leaders Must Take Immediate Action to Mitigate the Surging Cyber Threats--Upstream Report Reveals Critical Gaps

PR Newswire February 11, 2025

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 6, 2025

Upstream Bio Appoints Allison Ambrose as General Counsel

GlobeNewswire December 17, 2024

Upstream Bio Announces Addition to Russell 2000® Index

GlobeNewswire December 16, 2024

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire November 21, 2024

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire November 7, 2024
View More News ››

Opinion & Analysis (NDAQ:UPB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:UPB)

Be the first to post on this bullboard.

Africa Oil Corp.

Africa Oil Corp.

Africa Oil Corp. is a Canadian oil and gas company with producing and development assets in deepwater Nigeria, an interest in ...
View More »